Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

HAIC Combined with Lenvatinib and Pembrolizumab for Unresectable Hepatocellular Carcinoma: A Retrospective Study

Saved in:
Bibliographic Details
Published in:Journal of Hepatocellular Carcinoma
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867301678030520322
collection WordPress RSS
FRELIP Feed Integration
container_title Journal of Hepatocellular Carcinoma
description
discipline_display Communicable Diseases, Epidemiology
discipline_facet Communicable Diseases, Epidemiology
format Online Article
RSS Article
genre Journal Article
id rss_article:79406
institution FRELIP
journal_source_facet Journal of Hepatocellular Carcinoma
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle HAIC Combined with Lenvatinib and Pembrolizumab for Unresectable Hepatocellular Carcinoma: A Retrospective Study
Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
sub_discipline_display General
sub_discipline_facet General
subject_display Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
subject_facet Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
title HAIC Combined with Lenvatinib and Pembrolizumab for Unresectable Hepatocellular Carcinoma: A Retrospective Study
title_auth HAIC Combined with Lenvatinib and Pembrolizumab for Unresectable Hepatocellular Carcinoma: A Retrospective Study
title_full HAIC Combined with Lenvatinib and Pembrolizumab for Unresectable Hepatocellular Carcinoma: A Retrospective Study
title_fullStr HAIC Combined with Lenvatinib and Pembrolizumab for Unresectable Hepatocellular Carcinoma: A Retrospective Study
title_full_unstemmed HAIC Combined with Lenvatinib and Pembrolizumab for Unresectable Hepatocellular Carcinoma: A Retrospective Study
title_short HAIC Combined with Lenvatinib and Pembrolizumab for Unresectable Hepatocellular Carcinoma: A Retrospective Study
title_sort haic combined with lenvatinib and pembrolizumab for unresectable hepatocellular carcinoma: a retrospective study
topic Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
url https://www.dovepress.com/haic-combined-with-lenvatinib-and-pembrolizumab-for-unresectable-hepat-peer-reviewed-fulltext-article-JHC